gastric cancer
Genetron Health Targeting Liquid Biopsy, Early Cancer Detection for Future Business Growth
The Chinese company is branching out from its core genomics business to liquid biopsy cancer screening and monitoring as it eyes areas for global expansion.
Genetron Health Q3 Revenues Up 38 Percent
The Chinese company reported revenues of RMB112.0 million ($16.5 million), driven by growth in sales of both its LDT services and IVD products.
Singapore's MiRxes Sets Out to Sell Gastric Cancer Test Across Asia
The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test.
Genetron, CStone Launch Clinical Trial to Develop CDx for Cancer Drug Avapritinib
Avapritinib is sold by Blueprint Medicines as Ayvakit for the treatment of adults with unresectable or metastatic GIST harboring a PDGFRA exon 18 mutation.
AnchorDx Demonstrates Liquid Biopsy DNA Methylation Test for Early Cancer Detection
The company recently presented results from its Aurora assay for multi-cancer screening and plans to launch a $100 test for the US and Chinese markets.
Mar 21, 2019
Feb 20, 2019
Aug 21, 2018
FDA Clears Techlab's H. Pylori Tests
Nov 21, 2017
Sep 29, 2017